Molecular model of gefitinib. Gefitinib is a new medicine; a selective inhibitor of the epidermal growth factor receptor's (EGFR) tyrosine kinase domain. It binds to the adenosine triphosphate (ATP) binding site of the enzyme and in this way inhibits the growth of malignant cells. C22 H24 Cl F N4 O3. Carbon in grey; Hydrogen in white; Nitrogen in blue; Chlorine in yellow; Fluorine in green; Oxygen in red | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / SciMAT |
Taille de l’image : | 3078 px × 2172 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : |
|